Factors predicting for a favorable response among patients with myelodysplastic syndromes treated with erythropoietin G-CSF

被引：0
|
作者：
Symeonidis, A.
Kouraklis-Symeonidis, A.
Zikos, P.
Galanopoulos, A.
Psyllaki, M.
Aktypi, A.
Michalopoulou, S.
Michali, E.
Protopapa, M.
Pantelidou, D.
Papadaki, E.
Anagnostopoulos, N.
Zoumbos, N.
机构：
来源：
LEUKEMIA RESEARCH | 2007年 / 31卷
关键词：
D O I：
10.1016/S0145-2126(07)70210-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S116 / S117
页数：2
相关论文
共 50 条
  • [1] Treatment of myelodysplastic syndromes with erythropoietin and G-CSF
    Hellstrom-Lindberg, E.
    LEUKEMIA RESEARCH, 2007, 31 : S17 - S17
  • [2] Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF:: the GFM experience
    Park, Sophie
    Grabar, Sophie
    Kelaidi, Charikleia
    Beyne-Rauzy, Odile
    Picard, Francoise
    Bardet, Valerie
    Coiteux, Valerie
    Leroux, Genevieve
    Lepelley, Pascale
    Daniel, Marie-Therese
    Cheze, Stephane
    Mahe, Beatrice
    Ferrant, Augustin
    Ravoet, Christophe
    Escoffre-Barbe, Martine
    Ades, Lionel
    Vey, Norbert
    Aljassern, Lina
    Stamatoullas, Aspasia
    Mannone, Lionel
    Dombret, Herve
    Bourgeois, Keith
    Greenberg, Peter
    Fenaux, Pierre
    Dreyfus, Francois
    BLOOD, 2008, 111 (02) : 574 - 582
  • [3] Combined use of erythropoietin and G-CSF in the treatment of myelodysplastic syndromes
    不详
    HAEMATOLOGICA, 1999, 84 (12) : 1057 - 1057
  • [4] Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model
    HellstromLindberg, E
    Negrin, R
    Stein, R
    Krantz, S
    Lindberg, G
    Vardiman, J
    Ost, A
    Greenberg, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) : 344 - 351
  • [5] THE ROLE OF GM-CSF, G-CSF, INTERLEUKIN-3, AND ERYTHROPOIETIN IN MYELODYSPLASTIC SYNDROMES
    GANSER, A
    SEIPELT, G
    HOELZER, D
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 : S34 - S39
  • [6] Erythropoietic effectiveness and apoptosis in patients with myelodysplastic syndromes (MDS) treated with G-CSF and EPO.
    Kanter, L
    HellstromLindberg, E
    Kock, Y
    Rodensjo, M
    Ost, A
    BLOOD, 1995, 86 (10) : 1339 - 1339
  • [7] Efficacy of G-CSF and EPO on the anaemia in patients with myelodysplastic syndromes (MDS).
    HellstromLindberg, E
    Negrin, R
    Stein, R
    Krantz, S
    Vardiman, J
    Ost, A
    Lindberg, G
    Greenberg, P
    BLOOD, 1995, 86 (10) : 1340 - 1340
  • [8] GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) PLUS ERYTHROPOIETIN (EPO) TREATMENT OF MYELODYSPLASTIC SYNDROMES
    NEGRIN, RS
    DOHERTY, K
    STEIN, R
    VARDIMAN, J
    KRANTZ, S
    GREENBERG, PL
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 745 - 745
  • [9] Amifostine in combination with erythropoietin and G-CSF promotes multilineage hematopoiesis in patients with myelodysplastic syndrome
    Neumeister, P
    Jaeger, G
    Eibl, M
    Sormann, S
    Zinke, W
    Linkesch, W
    LEUKEMIA & LYMPHOMA, 2001, 40 (3-4) : 345 - 349
  • [10] INVITRO-INVIVO CORRELATIONS OF ERYTHROID RESPONSES TO G-CSF PLUS ERYTHROPOIETIN (EPO) IN MYELODYSPLASTIC SYNDROMES (MDS)
    GREENBERG, PL
    NEGRIN, RS
    GINZTON, N
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 733 - 733
12345